| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.946 | 61.530 | 54.179 | 54.613 | 53.982 | 76.496 | 77.761 | 89.985 | 84.312 | 73.870 |
| Total Income - EUR | 52.126 | 61.530 | 54.179 | 54.613 | 53.982 | 76.496 | 77.761 | 89.985 | 84.312 | 73.870 |
| Total Expenses - EUR | 26.670 | 23.407 | 23.330 | 33.341 | 36.182 | 34.441 | 34.918 | 38.941 | 28.201 | 27.282 |
| Gross Profit/Loss - EUR | 25.456 | 38.123 | 30.849 | 21.272 | 17.800 | 42.055 | 42.843 | 51.043 | 56.111 | 46.587 |
| Net Profit/Loss - EUR | 23.886 | 37.510 | 30.308 | 20.726 | 17.254 | 41.300 | 42.090 | 50.251 | 55.284 | 44.637 |
| Employees | 8 | 8 | 8 | 8 | 13 | 4 | 4 | 4 | 1 | 1 |
Check the financial reports for the company - Amso Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.836 | 5.641 | 4.439 | 3.272 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 50.359 | 56.055 | 32.019 | 63.676 | 86.229 | 126.959 | 75.513 | 91.957 | 71.387 | 76.459 |
| Inventories | 0 | 0 | 0 | 58 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.766 | 2.146 | 0 | 90 | 67 | 207 | 156 | 0 | 45.498 | 20.010 |
| Cash | 48.593 | 53.909 | 32.019 | 63.527 | 86.162 | 126.752 | 75.357 | 91.957 | 25.890 | 56.449 |
| Shareholders Funds | 43.428 | 37.741 | 32.374 | 52.506 | 68.743 | 108.740 | 62.027 | 89.259 | 55.333 | 54.418 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.767 | 23.955 | 4.084 | 14.442 | 17.487 | 18.219 | 13.486 | 2.698 | 16.054 | 22.042 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amso Med Srl